VIP and tolerance induction in autoimmunity
- Autores
- Rosignoli, F.; Torroba, M.; Juarranz, Y.; García Gómez, M.; Martinez, C.; Gomariz, R. P.; Perez Leiros, Claudia; Leceta, J.
- Año de publicación
- 2006
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Vasoactive intestinal peptide (VIP) is a potent antiinflammatory agent with immunoregulatory properties, skewing the immune response to a Th2 pattern of cytokine production. Here, we studied the effect of treatment with VIP in the development of diabetes in nonobese diabetic (NOD) mice, an annual model of type 1 diabetes. Mice treated with VIP from 4 weeks of age did not develop diabetes and showed milder insulitis than nontreated mice. The protective mechanism of VIP was associated with a reduction in the circulating levels of Th1 cytokines. In the pancreas of VIP-treated animals, regulatory T cell markers predominate, as indicated by the upregulation of FoxP3 and transforming growth factor-β (TGF-β), and the downregulation of the transcription factor, T-bet. These findings indicate that VIP restores tolerance to pancreatic islets by promoting the local differentiation and function of regulatory T cells.
Fil: Rosignoli, F.. Universidad Complutense de Madrid; España
Fil: Torroba, M.. Universidad Complutense de Madrid; España
Fil: Juarranz, Y.. Universidad Complutense de Madrid; España
Fil: García Gómez, M.. Universidad Complutense de Madrid; España
Fil: Martinez, C.. Universidad Complutense de Madrid; España
Fil: Gomariz, R. P.. Universidad Complutense de Madrid; España
Fil: Perez Leiros, Claudia. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Departamento de Química Biológica; Argentina
Fil: Leceta, J.. Universidad Complutense de Madrid; España - Materia
-
AUTOIMMUNE
FOXP3
TGF-Β
VIP - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
.jpg)
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/99385
Ver los metadatos del registro completo
| id |
CONICETDig_fb03a58a54e9e1690a9356bddcf732ed |
|---|---|
| oai_identifier_str |
oai:ri.conicet.gov.ar:11336/99385 |
| network_acronym_str |
CONICETDig |
| repository_id_str |
3498 |
| network_name_str |
CONICET Digital (CONICET) |
| spelling |
VIP and tolerance induction in autoimmunityRosignoli, F.Torroba, M.Juarranz, Y.García Gómez, M.Martinez, C.Gomariz, R. P.Perez Leiros, ClaudiaLeceta, J.AUTOIMMUNEFOXP3TGF-ΒVIPhttps://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3Vasoactive intestinal peptide (VIP) is a potent antiinflammatory agent with immunoregulatory properties, skewing the immune response to a Th2 pattern of cytokine production. Here, we studied the effect of treatment with VIP in the development of diabetes in nonobese diabetic (NOD) mice, an annual model of type 1 diabetes. Mice treated with VIP from 4 weeks of age did not develop diabetes and showed milder insulitis than nontreated mice. The protective mechanism of VIP was associated with a reduction in the circulating levels of Th1 cytokines. In the pancreas of VIP-treated animals, regulatory T cell markers predominate, as indicated by the upregulation of FoxP3 and transforming growth factor-β (TGF-β), and the downregulation of the transcription factor, T-bet. These findings indicate that VIP restores tolerance to pancreatic islets by promoting the local differentiation and function of regulatory T cells.Fil: Rosignoli, F.. Universidad Complutense de Madrid; EspañaFil: Torroba, M.. Universidad Complutense de Madrid; EspañaFil: Juarranz, Y.. Universidad Complutense de Madrid; EspañaFil: García Gómez, M.. Universidad Complutense de Madrid; EspañaFil: Martinez, C.. Universidad Complutense de Madrid; EspañaFil: Gomariz, R. P.. Universidad Complutense de Madrid; EspañaFil: Perez Leiros, Claudia. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Departamento de Química Biológica; ArgentinaFil: Leceta, J.. Universidad Complutense de Madrid; EspañaBlackwell Publishing2006-12info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/99385Rosignoli, F.; Torroba, M.; Juarranz, Y.; García Gómez, M.; Martinez, C.; et al.; VIP and tolerance induction in autoimmunity; Blackwell Publishing; Annals of the New York Academy of Sciences; 1070; 12-2006; 525-5300077-8923CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://nyaspubs.onlinelibrary.wiley.com/doi/full/10.1196/annals.1317.073info:eu-repo/semantics/altIdentifier/doi/10.1196/annals.1317.073info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-11-05T10:27:35Zoai:ri.conicet.gov.ar:11336/99385instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-11-05 10:27:36.099CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
| dc.title.none.fl_str_mv |
VIP and tolerance induction in autoimmunity |
| title |
VIP and tolerance induction in autoimmunity |
| spellingShingle |
VIP and tolerance induction in autoimmunity Rosignoli, F. AUTOIMMUNE FOXP3 TGF-Β VIP |
| title_short |
VIP and tolerance induction in autoimmunity |
| title_full |
VIP and tolerance induction in autoimmunity |
| title_fullStr |
VIP and tolerance induction in autoimmunity |
| title_full_unstemmed |
VIP and tolerance induction in autoimmunity |
| title_sort |
VIP and tolerance induction in autoimmunity |
| dc.creator.none.fl_str_mv |
Rosignoli, F. Torroba, M. Juarranz, Y. García Gómez, M. Martinez, C. Gomariz, R. P. Perez Leiros, Claudia Leceta, J. |
| author |
Rosignoli, F. |
| author_facet |
Rosignoli, F. Torroba, M. Juarranz, Y. García Gómez, M. Martinez, C. Gomariz, R. P. Perez Leiros, Claudia Leceta, J. |
| author_role |
author |
| author2 |
Torroba, M. Juarranz, Y. García Gómez, M. Martinez, C. Gomariz, R. P. Perez Leiros, Claudia Leceta, J. |
| author2_role |
author author author author author author author |
| dc.subject.none.fl_str_mv |
AUTOIMMUNE FOXP3 TGF-Β VIP |
| topic |
AUTOIMMUNE FOXP3 TGF-Β VIP |
| purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.1 https://purl.org/becyt/ford/3 |
| dc.description.none.fl_txt_mv |
Vasoactive intestinal peptide (VIP) is a potent antiinflammatory agent with immunoregulatory properties, skewing the immune response to a Th2 pattern of cytokine production. Here, we studied the effect of treatment with VIP in the development of diabetes in nonobese diabetic (NOD) mice, an annual model of type 1 diabetes. Mice treated with VIP from 4 weeks of age did not develop diabetes and showed milder insulitis than nontreated mice. The protective mechanism of VIP was associated with a reduction in the circulating levels of Th1 cytokines. In the pancreas of VIP-treated animals, regulatory T cell markers predominate, as indicated by the upregulation of FoxP3 and transforming growth factor-β (TGF-β), and the downregulation of the transcription factor, T-bet. These findings indicate that VIP restores tolerance to pancreatic islets by promoting the local differentiation and function of regulatory T cells. Fil: Rosignoli, F.. Universidad Complutense de Madrid; España Fil: Torroba, M.. Universidad Complutense de Madrid; España Fil: Juarranz, Y.. Universidad Complutense de Madrid; España Fil: García Gómez, M.. Universidad Complutense de Madrid; España Fil: Martinez, C.. Universidad Complutense de Madrid; España Fil: Gomariz, R. P.. Universidad Complutense de Madrid; España Fil: Perez Leiros, Claudia. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Departamento de Química Biológica; Argentina Fil: Leceta, J.. Universidad Complutense de Madrid; España |
| description |
Vasoactive intestinal peptide (VIP) is a potent antiinflammatory agent with immunoregulatory properties, skewing the immune response to a Th2 pattern of cytokine production. Here, we studied the effect of treatment with VIP in the development of diabetes in nonobese diabetic (NOD) mice, an annual model of type 1 diabetes. Mice treated with VIP from 4 weeks of age did not develop diabetes and showed milder insulitis than nontreated mice. The protective mechanism of VIP was associated with a reduction in the circulating levels of Th1 cytokines. In the pancreas of VIP-treated animals, regulatory T cell markers predominate, as indicated by the upregulation of FoxP3 and transforming growth factor-β (TGF-β), and the downregulation of the transcription factor, T-bet. These findings indicate that VIP restores tolerance to pancreatic islets by promoting the local differentiation and function of regulatory T cells. |
| publishDate |
2006 |
| dc.date.none.fl_str_mv |
2006-12 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/99385 Rosignoli, F.; Torroba, M.; Juarranz, Y.; García Gómez, M.; Martinez, C.; et al.; VIP and tolerance induction in autoimmunity; Blackwell Publishing; Annals of the New York Academy of Sciences; 1070; 12-2006; 525-530 0077-8923 CONICET Digital CONICET |
| url |
http://hdl.handle.net/11336/99385 |
| identifier_str_mv |
Rosignoli, F.; Torroba, M.; Juarranz, Y.; García Gómez, M.; Martinez, C.; et al.; VIP and tolerance induction in autoimmunity; Blackwell Publishing; Annals of the New York Academy of Sciences; 1070; 12-2006; 525-530 0077-8923 CONICET Digital CONICET |
| dc.language.none.fl_str_mv |
eng |
| language |
eng |
| dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://nyaspubs.onlinelibrary.wiley.com/doi/full/10.1196/annals.1317.073 info:eu-repo/semantics/altIdentifier/doi/10.1196/annals.1317.073 |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
| eu_rights_str_mv |
openAccess |
| rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
| dc.format.none.fl_str_mv |
application/pdf application/pdf |
| dc.publisher.none.fl_str_mv |
Blackwell Publishing |
| publisher.none.fl_str_mv |
Blackwell Publishing |
| dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
| reponame_str |
CONICET Digital (CONICET) |
| collection |
CONICET Digital (CONICET) |
| instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
| repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
| repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
| _version_ |
1847977931034329088 |
| score |
13.087074 |